View in EDS

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

Saved in:
Bibliographic Details
Title: Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Authors: Dieci, Maria Vittoria1,2 mariavittoriadieci@gmail.com, Radosevic-Robin, Nina3,4, Fineberg, Susan5,6, van den Eynden, Gert7,8, Ternes, Nils9,10, Penault-Llorca, Frederique3,4,11, Pruneri, Giancarlo12,13, D’Alfonso, Timothy M.14, Demaria, Sandra15, Castaneda, Carlos16, Sanchez, Joselyn16, Badve, Sunil17, Michiels, Stefan9,10, Bossuyt, Veerle18, Rojo, Federico19, Singh, Baljit20, Nielsen, Torsten21, Viale, Giuseppe22, Kim, Seong-Rim23, Hewitt, Stephen24
Source: Seminars in Cancer Biology. Oct2018:Part 2, Vol. 52, p16-25. 10p.
Database: Academic Search Ultimate
Description
ISSN:1044579X
DOI:10.1016/j.semcancer.2017.10.003